Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 12/20 | 0.57 |
| ▸ | CYP1B1 | Q16678 | 12/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 11/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | FBP1 | P09467 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23474551 | 1.00 | CYP1A1 (0.57) | CYP1A1CYP1B1CYP1A2ALDH1A1FBP1 | |
| SCHEMBL5188569 | 1.00 | CYP1A1 (0.57) | CYP1A1CYP1B1CYP1A2ALDH1A1FBP1 | |
| SCHEMBL7567897 | 0.87 | CYP1A1 (0.71) | CYP1A1CYP1B1CYP1A2ALDH1A1FBP1 | |
| SCHEMBL13790333 | 0.87 | CYP1A1 (0.71) | CYP1A1CYP1B1CYP1A2ALDH1A1FBP1 | |
| SCHEMBL8367958 | 0.87 | CYP1A1 (0.71) | CYP1A1CYP1B1CYP1A2ALDH1A1FBP1 | |
| SCHEMBL13790243 | 0.87 | CYP1A1 (0.71) | CYP1A1CYP1B1CYP1A2ALDH1A1FBP1 | |
| SCHEMBL7661993 | 0.82 | CYP3A4 (0.50) | CYP1A1CYP1B1CYP1A2ALDH1A1FBP1 | |
| SCHEMBL2622608 | 0.82 | CYP1A1 (0.59) | CYP1A1CYP1B1CYP1A2ALDH1A1FBP1 | |
| SCHEMBL9461723 | 0.81 | CYP3A4 (0.65) | ALDH1A1LMNATP53CYP3A4TSHR | |
| SCHEMBL7527708 | 0.81 | CYP3A4 (0.65) | ALDH1A1LMNATP53CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572636-B1 | ALKYLSULFANYL-BENZENES AS FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2007-07-18 | — | — | EP | claimed |
| US-20060014664-A1 | Alkylsulfanyl- benzenes as fragrance compounds | GIVAUDAN SA (CH) | 2006-01-19 | — | — | US | claimed |
| EP-1572636-A1 | ALKYLSULFANYL-BENZENES AS FRAGRANCE COMPOUNDS | Givaudan SA (CH) | 2005-09-14 | — | — | EP | claimed |
| WO-2004056765-A1 | ALKYLSULFANYL-BENZENES AS FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2004-07-08 | — | — | WO | claimed |
| EP-1572636-B1 | ALKYLSULFANYL-BENZENES AS FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2007-07-18 | — | — | EP | disclosed |
| US-20060014664-A1 | Alkylsulfanyl- benzenes as fragrance compounds | GIVAUDAN SA (CH) | 2006-01-19 | — | — | US | disclosed |
| EP-1572636-A1 | ALKYLSULFANYL-BENZENES AS FRAGRANCE COMPOUNDS | Givaudan SA (CH) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004056765-A1 | ALKYLSULFANYL-BENZENES AS FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2004-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014664-A1 | Alkylsulfanyl- benzenes as fragrance compounds | C1S, TRPA1, CYP2S1 | CYP1A1 6/4885CYP1B1 4/4885CYP1A2 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.